Pharmalot... Pharmalittle... Good Morning

Rise and shine, another busy day is on the way. Already this week, there has been a fast-paced medical conference, a contentious court ruling and a controversial FDA panel meeting, which continues today. What else may arise? We are uncertain, but are keeping watch and, meanwhile, planning some interesting items. For now, please enjoy some tidbits, and a cup of stimulation, as we always do. Have a great day and keep us in mind for interesting developments... Tysabri Screening Test May Be Unreliable (MedPage Today) India Reconsiders Revocation Of Pfizer Sutent Patent (The Hindu) Non-Profit To Be Formed For Sharing Genetic And Clinical Data (Pharma Times) J&J Invests In The Human Microbiome (Forbes) Royalty Pharma Raises Elan Bid (Bloomberg News) Drug Shortages Threaten Fight Against Tuberculosis (Wall Street Journal) Celgene's Revlimid Wins Expanded Use For Blood Cancer (Bloomberg News) Vaccine Exemptions Tied To Rising Cases Of Whooping Cough (Reuters) ...Read more
Source: Pharmalot - Category: Pharma Commentators Authors: Source Type: blogs